[Multicenter study. Early summer meningoencephalitis: an added dose for patients with rheumatoid arthritis?].
D000368:Aged; D000914:Antibodies, Viral / Q000097:blood*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology*; D004305:Dose-Response Relationship, Drug; D004669:Encephalitis Viruses, Tick-Borne / Q000276:immunology*; D004675:Encephalitis, Tick-Borne / Q000276:immunology* / Q000517:prevention & control*; D006801:Humans; D007117:Immunization, Secondary; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D008875:Middle Aged; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology
D000914:Antibodies, Viral; D007166:Immunosuppressive Agents; D014765:Viral Vaccines